181 related articles for article (PubMed ID: 37815883)
1. Paroxetine protects against bleomycin-induced pulmonary fibrosis by blocking GRK2/Smad3 pathway.
Zhao K; Nie H; Tang Z; Chen G; Huang J
Aging (Albany NY); 2023 Oct; 15(19):10524-10539. PubMed ID: 37815883
[TBL] [Abstract][Full Text] [Related]
2. GRK2 promotes activation of lung fibroblast cells and contributes to pathogenesis of pulmonary fibrosis through increasing Smad3 expression.
Li Y; Sun Y; Wu N; Ma H
Am J Physiol Cell Physiol; 2022 Jan; 322(1):C63-C72. PubMed ID: 34852209
[TBL] [Abstract][Full Text] [Related]
3. Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway.
Li L; Zhao J; Zhou L; Chen J; Ma Y; Yu Y; Cheng J
Respir Res; 2019 Jul; 20(1):163. PubMed ID: 31331325
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
5. Lysine-specific demethylase-1 regulates fibroblast activation in pulmonary fibrosis via TGF-β1/Smad3 pathway.
Pan X; Li J; Tu X; Wu C; Liu H; Luo Y; Dong X; Li X; Pan LL; Sun J
Pharmacol Res; 2020 Feb; 152():104592. PubMed ID: 31830521
[TBL] [Abstract][Full Text] [Related]
6. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
Jia L; Yang M; Tian X; Zhao P; Mei X; Bai Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1161-1166. PubMed ID: 36567559
[TBL] [Abstract][Full Text] [Related]
7. Derrone Targeting the TGF Type 1 Receptor Kinase Improves Bleomycin-Mediated Pulmonary Fibrosis through Inhibition of Smad Signaling Pathway.
Molagoda IMN; Sanjaya SS; Lee KT; Choi YH; Lee JH; Lee MH; Kang CH; Lee CM; Kim GY
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108428
[TBL] [Abstract][Full Text] [Related]
8. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
9. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats.
Song X; Liu W; Xie S; Wang M; Cao G; Mao C; Lv C
Lab Invest; 2013 Nov; 93(11):1219-31. PubMed ID: 24042439
[TBL] [Abstract][Full Text] [Related]
10. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
Gao L; Jiang D; Geng J; Dong R; Dai H
Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
[TBL] [Abstract][Full Text] [Related]
12. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
[TBL] [Abstract][Full Text] [Related]
13. Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin.
Zhou Y; Koli K; Hagood JS; Miao M; Mavalli M; Rifkin DB; Murphy-Ullrich JE
Am J Pathol; 2009 Jan; 174(1):21-33. PubMed ID: 19056849
[TBL] [Abstract][Full Text] [Related]
14. Mutant soluble ectodomain of fibroblast growth factor receptor-2 IIIc attenuates bleomycin-induced pulmonary fibrosis in mice.
Yu ZH; Wang DD; Zhou ZY; He SL; Chen AA; Wang J
Biol Pharm Bull; 2012; 35(5):731-6. PubMed ID: 22687409
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of microbial biosurfactants produced by Bacillus halotolerans and Candida parapsilosis on bleomycin-induced pulmonary fibrosis in mice: Impact of antioxidant, anti-inflammatory and anti-fibrotic properties via TGF-β1/Smad-3 pathway and miRNA-326.
Mousa AM; Nooman MU; Abbas SS; Gebril SM; Abdelraof M; Al-Kashef AS
Toxicol Appl Pharmacol; 2024 May; 486():116939. PubMed ID: 38643951
[TBL] [Abstract][Full Text] [Related]
16. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
17. Selpercatinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
Li S; Liu Z; Jiao X; Gu J; Liu Z; Meng L; Li W; Zhang T; Liu J; Chai D; Liu J; Yang Z; Liu Y; Jiao R; Li X; Zhou H; Zhang Y
Biochem Pharmacol; 2024 Jul; 225():116282. PubMed ID: 38762147
[TBL] [Abstract][Full Text] [Related]
18. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
[TBL] [Abstract][Full Text] [Related]
19. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
Kim S; Lim JH; Woo CH
Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
[TBL] [Abstract][Full Text] [Related]
20. Nesfatin-1, a novel energy-regulating peptide, alleviates pulmonary fibrosis by blocking TGF-β1/Smad pathway in an AMPKα-dependent manner.
Zhang R; Liang H; Liu G; Jiang W; Tang Z; Fan Q; Nie Z; Hu H; Kang G; Xie S
Int Immunopharmacol; 2023 Jul; 120():110369. PubMed ID: 37224650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
